Learn more

MEDEIKON CORP

Overview
  • Total Patents
    24
About

MEDEIKON CORP has a total of 24 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets measurement, medical technology and optics are ILLUMISONICS INC, RES FOUNDATION OF CITY COLLEGE and SHENZHEN CERTAINN TECHNOLOGY CO LTD.

Patent filings in countries

World map showing MEDEIKON CORPs patent filings in countries

Patent filings per year

Chart showing MEDEIKON CORPs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Alphonse Gerard A 20
#2 Carlin Donald B 8
#3 Ajgaonkar Mahesh 5
#4 Rappaport Fred 4
#5 Toma Christian 3
#6 Comizzoli Robert 2
#7 Ajgaonkar Mahesh U 2
#8 Rohatgi Rajeev 2
#9 Nguyen Michael 2
#10 Paunescu Alexandru 1

Latest patents

Publication Filing date Title
US2007285669A1 Polarization insensitive multiple probe
WO2007134039A2 Interferometric characterization of ablated tissue
US2008262442A1 Connectors for multi fiber optical probes
US2007292090A1 Low reflection lateral output fiber probe
US2007055117A1 Low coherence interferometry utilizing phase
US2007278389A1 Multi-channel low coherence interferometer
WO2006014993A1 Device for tissue characterization
WO2005114094A1 Method and system of low coherence interferometry for analyzing biological samples
WO2005114150A1 Low coherence interferometric system for optical metrology
US2005254060A1 Low coherence interferometry for detecting and characterizing plaques
US2005254061A1 Low coherence interferometry for detecting and characterizing plaques
WO2005058154A1 Method for monitoring of analytes in biological samples using low coherence interferometry
US2006103850A1 Single trace multi-channel low coherence interferometric sensor
EP1831638A1 Single trace multi-channel low coherence interferometric sensor
US2005254057A1 Low coherence interferometry utilizing phase